Company Overview of Limerick BioPharma, Inc.
Limerick BioPharma, Inc. develops pharmaceutical products with attenuated tissue specific toxicity. It develops methods for simulating activity of the blood-tissue barriers in vitro and in vivo. The company was formerly known as Limerick NeuroSciences, Inc. and changed its name in September 2008. Limerick BioPharma, Inc. was founded in 2004 and is based in South San Francisco, California.
601 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2004
Key Executives for Limerick BioPharma, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Limerick BioPharma, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.